Cresco Labs Inc. (CRLBF)
About Cresco Labs Inc.
CRESCO LABS INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $655.8M
- Net income
- -$135.4M
- Total assets
- $1.2B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Cresco Labs Inc. (CRLBF) Stock Price
- Reported a net loss of $135.4M in FY2025.
- Trading 65% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Cresco Labs Inc..
Write a review
News about Cresco Labs Inc.
News & sentiment via Polygon.io
Cresco Labs Inc.: frequently asked questions
Is Cresco Labs Inc. an American company?
Cresco Labs Inc. is a US-based company headquartered in Chicago, Illinois, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Cresco Labs Inc. headquartered?
Cresco Labs Inc. is headquartered in Chicago, Illinois, United States.
Is Cresco Labs Inc. publicly traded?
Yes — Cresco Labs Inc. is a publicly traded company. Its stock trades under the ticker symbol CRLBF on the OTC.
What does Cresco Labs Inc. do?
Cresco Labs Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
